跳至主要内容
临床试验/IRCT201407151556N61
IRCT201407151556N61已完成2 期

Cilostazol as an add-on therapy in men with chronic schizophrenia: a randomized double blind and placebo controlled trial

Tehran University of Medical Sciences0 个研究点目标入组 50 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 60 years(—)
性别
All

入选标准

  • 1-Diagnosis of Schizophrenia based on DSM- IV criteria; 2- Minimum Score of 60 on Positive and Negative Scale; 3- Age between 18-60; 4-Chronic Schizophrenia- duration of the disorder more than 2 years; 5-Minimum score of 20 in negative sub score.
  • Exclusion criteria:1-Any other mental disorder on axis I; 2-Any serious medical or neurological problem; 3- IQ less than 70; 4- Substance dependence during the last 6 months(except for nicotine and caffeine); 5-receiving oral antipsychotic medications during the last week or receiving any depot antipsychotic medication during the last month; 6-receiving ECT during the last 14 days ; 7-Hepatic and renal diseases; 8- History of neurosurgery; 9- History of head trauma.

排除标准

  • 未提供

研究者

相似试验